DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment.
McMullen M, Karakasis K, Loembe B, Dean E, Parr G, Oza AM.
Int J Gynecol Cancer. 2020 Sep 2:ijgc-2020-001694. doi: 10.1136/ijgc-2020-001694. Epub ahead of print.